COMPOSITIONS FOR CONTINUOUS ADMINISTRATION OF DOPA DECARBOXYLASE INHIBITORS

Disclosed herein are pharmaceutically acceptable liquid compositions comprising arginine and a combination of carbidopa and levodopa as active agents suitable for continuous administration for treating neurological or movement diseases or disorders such as restless leg syndrome, Parkinson's dis...

Full description

Saved in:
Bibliographic Details
Main Authors Yacoby-Zeevi, Oron, Nemas, Mara
Format Patent
LanguageEnglish
French
German
Published 17.02.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed herein are pharmaceutically acceptable liquid compositions comprising arginine and a combination of carbidopa and levodopa as active agents suitable for continuous administration for treating neurological or movement diseases or disorders such as restless leg syndrome, Parkinson's disease, secondary parkinsonism, Huntington's disease, Parkinson's-like syndrome, PSP, MSA, ALS, Shy-Drager syndrome and conditions resulting from brain injury including carbon monoxide or manganese intoxication.
Bibliography:Application Number: EP20200197759